BioCentury
ARTICLE | Clinical News

Sepranolone: Preliminary Phase II data

June 16, 2014 7:00 AM UTC

Umecrine's Umecrine Mood AB subsidiary reported preliminary data from an exploratory, double-blind, Swedish Phase II trial in 120 patients with PMDD showing that subcutaneous UC1010 missed the primary...